Abstract：
The transcatheter edge-to-edge mitral valve repair (TEER) has been recommended as a reliable treatment option for selected patients with severe degenerative and functional mitral regurgitation (MR). Although MR patients with rheumatic etiology were excluded from two significant trials (EVEREST II and COAPT) that established a role for the TEER in degenerative and functional MR. However, it has been reported that the TEER procedure could be safely and effectively performed in carefully selected rheumatic MR patients. Therefore, we share a case report of successfully treating severe rheumatic MR using a novel-designed TEER system (JensClipTM).
摘要：
经导管边缘对边缘二尖瓣修复术（TEER）已被推荐为严重退行性和功能性二尖瓣反流（MR）患者的可靠治疗选择。尽管有风湿性的MR患者被排除在两项重要的试验（EVERESTII和COAPT）之外，这些试验确立了TEER在退行性和功能性MR中的作用。然而,据报道,TEER手术可安全有效地应用于精心挑选的风湿性MR患者.因此,我们分享了一例使用新型TEER系统(JensClipTM)成功治疗严重风湿性MR的病例报告.
